Compared to the placebo group, the NBP group showed a greater rCBF improvement from baseline to 12 weeks (media 3.7%; 95% CI −0.1 to 7.4), although this improvement did not reach statistical significance ( p = 0.059).
← all excerpts
Effect of DL-3-n-Butylphthalide on Cerebral Hypoperfusion Due to Atherosclerotic Stenosis: A Multicenter, Double-Blind, Randomized Controlled, Preliminary Trial.
1
0.0590
0.0590